 |
Transitioning to the 'Next Normal': Biopharma's Role in Addressing the COVID-19 Crisis and What's Next
With insights from McKinsey & Company
Friday, October, 15, 2021, 7:45 a.m. - 2:30 p.m.
Bridgewater Marriott*
|
As we look ahead to our "Next Normal", join BioNJ and industry experts on Friday, October 15, for BioNJ's C-Suite Summit, to reflect on this past year's successes and challenges, discuss the next wave of innovation across the value chain, and to share thoughts on how the industry might deepen and scale its commitment to delivering positive impact for society.
|
|
Please join us and our ALL-STAR LINEUP of industry leaders!
|
|
|
|
| |
Jacqueline Berman
Partner
Morgan Lewis
|
Steve Bryant, Ph.D.
Vice President, & Head of Global Business Development
Genmab
|
Gerry Collins
Global Platform Leader Parenterals Janssen, Pharmaceutical
Companies of Johnson and Johnson
|
Tamara Elias, M.D.
Vice President
Global Partnerships & Innovation, MSD
Merck & Co.
| |
|
|
|
| |
Joseph Goldberg
Director, Strategy & Management Consulting, National Life Sciences Industry Consulting Leader
RSM US LLP
|
Debbie Hart
President & CEO
BioNJ
|
Ben Hohn
Principal
Business Development, Pipeline & Launch Strategy & Emerging Pharma Lead
ZS Associates
|
Daniel Karp
Senior Vice President
& Head
Business Development
Organon
| |
|
|
|
| |
Michael Ku, PharmD
Vice President Global Clinical Supply,
Pfizer
|
Elliott Levy, M.D.
Senior Vice President R&D Strategy & Operations
Amgen
|
Fred Lowery
Senior Vice President
Thermo Fisher & President
Customer Channels
Thermo Fisher Scientific
|
Peter Marks M.D., Ph.D., Director
Center for Biologics Evaluation and Research
Food & Drug Administration
| |
|
|
|
|
Innes Meldrum
Senior Vice President & Chief Commercial Officer
Otsuka
|
Elizabeth Naldi-Jacob
Head of Oncology Business Development for Corporate Development & GHH
Merck & Co.
|
Lucy Perez, Ph.D.
Senior Partner
McKinsey & Company
|
Brent Ragans
President
Ferring Pharmaceuticals
| |
|
|
| |
Geralyn Ritter
Executive Vice President,
External Affairs & ESG
Organon
|
Stefan Roehr
Head, North America Supply Chain, Distribution & Logistics
Sanofi
|
Arda Ural, Ph.D.
Americas Industry Market Leader - HS&W, Life Sciences & Healthcare
Ernst & Young LLP
| |
|
Topics include...
- An Imperative to Lead Presented by McKinsey & Company
- Striding into a "New Normal"
- Fireside Chat With Dr. Peter Marks, FDA: A Rapidly Evolving Regulatory Landscape
- Digital Patient and HCP Engagement in a Post-COVID World
- Value Creation in the Industry
- Rethinking Resilience - The Global Supply Chain
- Plus, network with industry colleagues during a Luncheon and Closing Reception!
|
|
|
Join us for this important conversation. Click here to register. Registration for the event is $595 for Members of BioNJ and affiliated organizations and $795 for future BioNJ Members. Contact Kim Minton at [email protected] to learn about Sponsorship opportunities and place your company in the spotlight.
|
*SPECIAL COVID-19 NOTE: BioNJ's intention at this time is to be in person for this year's C-Suite Summit. We will continue to monitor the COVID-19 situation and make adjustments to protocols as needed, such as the possibility of requiring masks, social distancing, proof of vaccination and even possibly moving to a virtual event. Should BioNJ be required to reduce crowd size, we will handle on a first-come, first-served basis.
|
|
Thank You To Our Sponsors
|
|
|
|
|
